Your browser doesn't support javascript.
loading
A review of methylene blue treatment for cardiovascular collapse.
Lo, Jean C Y; Darracq, Michael A; Clark, Richard F.
Affiliation
  • Lo JC; Department of Toxicology, University of California, San Diego, San Diego, California.
  • Darracq MA; Department of Toxicology, University of California, San Diego, San Diego, California.
  • Clark RF; Department of Toxicology, University of California, San Diego, San Diego, California.
J Emerg Med ; 46(5): 670-9, 2014 May.
Article in En | MEDLINE | ID: mdl-24508113
ABSTRACT

BACKGROUND:

Historically, methylene blue (MB) has been used for multiple purposes, including as an antidote for toxin-induced and hereditary methemoglobinemia, ifosfamide-induced encephalopathy, and ackee fruit and cyanide poisoning; as an aniline dye derivative, antimalarial agent, and antidepressant.

DISCUSSION:

Most recently, the use of MB has been advocated as a potential adjunct in the treatment of shock states. Our article reviews the role of MB in septic shock, anaphylactic shock, and toxin-induced shock. MB is proposed to increase blood pressure in these shock states by interfering with guanylate cyclase activity, and preventing cyclic guanosine monophosphate production and vasodilatation.

SUMMARY:

MB may be an adjunct in the treatment of septic shock, anaphylactic shock, and toxin-induced shock.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Shock / Enzyme Inhibitors / Anaphylaxis / Methylene Blue Limits: Humans Language: En Journal: J Emerg Med Journal subject: MEDICINA DE EMERGENCIA Year: 2014 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Shock / Enzyme Inhibitors / Anaphylaxis / Methylene Blue Limits: Humans Language: En Journal: J Emerg Med Journal subject: MEDICINA DE EMERGENCIA Year: 2014 Document type: Article